New Medications Fail to Show Efficacy for Alzheimer’s Disease
Mad In America,
Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease…
Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease…
Results suggest the drug boosts cognition when given alongside the acetylcholinesterase inhibitor.
Accelerating the development of innovative treatments for Alzheimer’s disease and related dementias is the target for…